What is CVE-2022-1554?

CVE-2022-1554 is a high-severity vulnerability in Clinical-Genomics Clinical-Genomics/scout, classified under Absolute Path Traversal. CVSS score: 7.5/10. Published 2022-05-03.

How severe is CVE-2022-1554?

High severity. CVSS v3 base score is 7.5 out of 10.

Path Traversal in Clinical-Genomics Clinical-Genomics/scout

CVE-2022-1554

Path Traversal due to `send_file` call in GitHub repository clinical-genomics/scout prior to 4.52.

EPSS: 0.013 (68.2th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.

Affected products

Clinical-genomics Clinical-genomics/scout — versions unspecified
Clinical-genomics Scout

Weakness classification (CWE)

CWE-36 — Absolute Path Traversal
CWE-22 — Path Traversal

References

security@huntr.dev (x_refsource_CONFIRM, Exploit, Patch, Third Party Advisory)
security@huntr.dev (Patch, Third Party Advisory, x_refsource_MISC)

Frequently asked questions

What is CVE-2022-1554?: CVE-2022-1554 is a high-severity vulnerability in Clinical-Genomics Clinical-Genomics/scout, classified under Absolute Path Traversal. CVSS score: 7.5/10. Published 2022-05-03.
How severe is CVE-2022-1554?: High severity. CVSS v3 base score is 7.5 out of 10.